Ethmozine

   
Google
 
Web NewDrugInformation.com

Ethmozine


Drug - Ethmozine
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Moricizine Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 200MG
The potency of the active ingredient(s), Moricizine Hydrochloride. May repeat for multiple part products.

Applicant - SHIRE
The firm name holding legal responsibility for Ethmozine. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 019753
The FDA assigned number to Ethmozine. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Ethmozine. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jun 19, 1990
The date Ethmozine was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Ethmozine. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Ethmozine is in. Format is RX, OTC, DISCN.

Applicant Full Name - Shire Development Inc
The full name of the firm holding legal responsibility for the new application of Ethmozine.

Ethmozine